30results about How to "Prevent and reduce infection" patented technology

The invention is directed to immunogenic compositions and methods for inducing an immune response against Piscine reoviruses in an animal. In another aspect, the invention relates to antibodies that bind Piscine reovirus poplypeptides. In yet another aspect, the invention relates to methods for preventing, or reducing PRV infection in an animal.

The invention relates to a cosmetic freeze-dried powder preparation capable of beautifying features and caring skin and an application of the cosmetic freeze-dried powder preparation capable of beautifying features and caring skin to solutions. The cosmetic freeze-dried powder preparation capable of beautifying features and caring skin is prepared from the following raw material components in percentage by mass of 1%-5% of hyaluronic acid, 0.001%-0.005% of antibacterial peptide, 5%-15% of an excipient and 79.995%-93.999% of water. The cosmetic freeze-dried powder preparation capable of beautifying features and caring skin is prepared through the steps of stirring the raw materials, performing heating, and after the raw materials completely dissolve, performing sublimation through a freeze-drying technique to obtain the freeze-dried powder preparation. The cosmetic freeze-dried powder preparation capable of beautifying features and caring skin can be applied to raw liquor, essence, enzyme dissolving liquor or liquid dressing. Through the adoption of the cosmetic freeze-dried powder preparation capable of beautifying features and caring skin disclosed by the invention, the phenomenathat water-oil disequilibrium of skin and muscle appears, and pores are easy to block can be avoided, besides, the stability of the antibacterial peptide in the freeze-dried powder preparation can beimproved, the effects of the freeze-dried powder preparation for resisting bacteria, diminishing inflammation and preventing occurrence and development of acne can be exerted, and the function of repairing skin and muscle can be better realized.

The present invention pertains to a vaccine for use in protecting offspring of a sow against an infection with porcine endemic diarrhea virus (PEDV), the vaccine comprising non-live PEDV antigen and an oil containing adjuvant, by administration of the vaccine to the pregnant sow at a dose of the antigen corresponding to at least 3.0E6 TCID50 killed whole PEDV. The invention also pertains to a method of protecting young piglets against an infection with porcine endemic diarrhea virus (PEDV).

The present invention pertains to a vaccine comprising non live Lawsonia intracellularis antigen and a pharmaceutically acceptable carrier for use in a method to reduce in a pig the negative impact on average daily weight gain (ADWG) associated with subclinical infection with Lawsonia intracellularis, by systemic administration of the vaccine to the pig.

The present invention provides novel multi-functional (e.g., repelling biofilms, promoting formation of minerals, and having anti-infection properties) biocomposites and methods of use thereof. In various embodiments, the present invention also provides method for simultaneously treating biofilms, promoting mineralization, treating infection, or any combination thereof.

The invention relates to a limb wound shield, which is convenient to be used and has the protective effects for wounds. The invention comprises a bottom plate, an arc-shaped covering; two bottom edges of the covering are respectively provided with bottom plate frame; the bottom plate frame is integrated with the covering into a whole and the bottom plate is inwardly opened with a horizontal continuous groove from front to back; right and left sides of the bottom plate are located inside the horizontal continuous groove, and the bottom plate is connected with the bottom plate frame and is capable of sliding from front to back.

The subject application provides a genetically modified recombinant facultative intracellular invasive bacterial pathogen (RFIIBP) or a recombinant attenuated Salmonella vaccine (RASV) strains encoding Zika virus (ZIKV) antigens. These strains exhibit high immunogenicity, complete safety, and attenuation, and are unable to persist or be shed in an infective or viable form. These RFIIBPs and RASVs also exhibit regulated delayed attenuation in vivo, regulated delayed in vivo synthesis of protective ZIKV antigens. Methods of inducing mucosal, systemic and cellular immunities in hosts are also provided and antibodies produced using the disclosed RFIIBPs and RASVs can comprise neutralizing antibodies against ZIKV that do not crossreact with Dengue virus (DENV).

A composition for preventing or reducing harmful effects of protozoal infection is provided, comprising in one embodiment a yeast cell wall and a preparation derived from oregano. The composition may further include a mineral nutrient selected from selenium and / or zinc. The composition may also include a preparation derived from Yucca. Efficacy of the composition is shown against a variety of protozoal organisms.

A sterilization apparatus for sterilizing air includes an outer housing having side walls extending between opposed bottom and top walls that, together, define an outer chamber. An inner housing is situated in the outer chamber and includes opposed top and bottom ends and having a wall structure that defines a sealed inner chamber extending therebetween. The wall structure includes at least one side wall that defines a transparent window. An inlet port is in communication with one end of the inner chamber and that directs unsterilized air into the inner chamber. An ultraviolet (“UV”) light source is positioned outwardly adjacent the window and configured to emit UV light through the window and into the inner chamber when energized so as to sterilize air in the inner chamber. An outlet port is in communication with another end of the inner chamber that directs sterilized air downstream from the inner chamber.

The present invention relates to methods for identifying the presence or elevated levels of IgG2 specific for O-antigen of Gram-negative bacteria in a subject. The method comprises providing a binding agent specific for said IgG2, contacting the binding agent with the sample, allowing the binding agent and IgG2 to form a complex and thereafter directly or indirectly detecting the complex. Also provided are methods for assessing the severity of infection and / or a worsening of a patient's condition. The present invention also relates to isolated O-antigens.

The present invention includes novel cyclic peptides, and methods of using the same. The present invention further includes novel cyclic peptides conjugated with a gold nanoparticle, and methods of using the same.

The present invention pertains to a vaccine comprising non live Lawsonia intracellularis antigen and a pharmaceutically acceptable carrier for use in a method to reduce in a pig the shedding of Lawsonia intracellularis bacteria associated with subclinical infection with Lawsonia intracellularis, by systemic administration of the vaccine to the pig.

The present invention relates to an arthroscopy apparatus, comprising at least three elements selected from: a conventional arthroscopic lens (12), to which there is coupled a power supply device or capsule, in the inside of which is the power source (1), and a miniature camera (8), characterized by not comprising connecting cables.